Published in Oral Oncol on July 01, 2001
Areca nut in pathogenesis of oral submucous fibrosis: revisited. Oral Maxillofac Surg (2011) 1.14
Prognostic role of Oct4, CD44 and c-Myc in radio-chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient mice. Clin Oral Investig (2015) 0.82
Expression of Proliferating Cell Nuclear Antigen (PCNA) in Oral Submucous Fibrosis: An Immunohistochemical Study. J Clin Diagn Res (2015) 0.75
EIYMNVPV Motif is Essential for A1CF Nucleus Localization and A1CF (-8aa) Promotes Proliferation of MDA-MB-231 Cells via Up-Regulation of IL-6. Int J Mol Sci (2016) 0.75
Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis. Onco Targets Ther (2017) 0.75
Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis. J Dent Res Dent Clin Dent Prospects (2015) 0.75
Epithelial expression of keratinocytes growth factor in oral precancer lesions. Dent Res J (Isfahan) (2016) 0.75
Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell Immunol (1994) 1.04
Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry. Oncology (2001) 0.92
Intraoperative radioimmunolocalization of colorectal carcinoma with a hand-held gamma probe and MAb B72.3: comparison of in vivo gamma probe counts with in vitro MAb radiolocalization. Int J Cancer (1988) 0.81
Transforming growth factor-alpha overexpression in proliferative verrucous leukoplakia and oral squamous cell carcinoma: an immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 0.80
Tumor-associated antigen expression of primary and metastatic colon carcinomas detected by monoclonal antibody 17-1A. Am J Clin Pathol (1987) 0.80
Veterinary and human biobanking practices: enhancing molecular sample integrity. Vet Pathol (2013) 0.79
Immunohistochemical staining for ganglioside GD1b as a diagnostic and prognostic marker for primary human brain tumors. Neuro Oncol (1999) 0.78